D
CytoDyn Inc.
CYDY
$0.2041
-$0.0317-13.44%
D
Sell
2/21/2025Upgraded
CytoDyn Inc. (CYDY) was upgraded to D- from E+ on 2/21/2025 due to an increase in the total return index, volatility index and solvency index.
CytoDyn Inc. (CYDY) was upgraded to D- from E+ on 2/21/2025 due to an increase in the total return index, volatility index and solvency index.
E
Sell
3/14/2023Downgrade
CytoDyn Inc. (CYDY) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index, total return index and valuation index.
CytoDyn Inc. (CYDY) was downgraded to E+ from D- on 3/14/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell
2/23/2023Upgraded
CytoDyn Inc. (CYDY) was upgraded to D- from E+ on 02/23/2023.
CytoDyn Inc. (CYDY) was upgraded to D- from E+ on 02/23/2023.
E
Sell
2/8/2023Downgrade
CytoDyn Inc. (CYDY) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.04 to 0.02, and debt to equity increased from -0.39 to -0.32.
CytoDyn Inc. (CYDY) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.04 to 0.02, and debt to equity increased from -0.39 to -0.32.
D
Sell
1/6/2023Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 1/6/2023 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 83.22% from -$6.04M to -$11.07M.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 1/6/2023 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 83.22% from -$6.04M to -$11.07M.
D
Sell
5/5/2022Upgraded
CytoDyn Inc. (CYDY) was upgraded to D from D- on 5/5/2022 due to an increase in the volatility index.
CytoDyn Inc. (CYDY) was upgraded to D from D- on 5/5/2022 due to an increase in the volatility index.
D
Sell
4/20/2022Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 4/20/2022 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.08 to 0.01, and debt to equity increased from -3.47 to -1.59.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 4/20/2022 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.08 to 0.01, and debt to equity increased from -3.47 to -1.59.
D
Sell
11/23/2021Upgraded
CytoDyn Inc. (CYDY) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
CytoDyn Inc. (CYDY) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 11/8/2021 due to a significant decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.22 to 0.05, and debt to equity increased from -2.99 to -2.04.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 11/8/2021 due to a significant decline in the total return index, volatility index and solvency index. The quick ratio declined from 0.22 to 0.05, and debt to equity increased from -2.99 to -2.04.
D
Sell
8/14/2020Downgrade
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 8/14/2020 due to a substantial decline in the solvency index, efficiency index and total return index. Net income declined 61.07% from -$35.77M to -$57.61M.
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 8/14/2020 due to a substantial decline in the solvency index, efficiency index and total return index. Net income declined 61.07% from -$35.77M to -$57.61M.
D
Sell
4/13/2020Downgrade
CytoDyn Inc. (CYDY) was downgraded to D+ from C on 4/13/2020 due to a significant decline in the efficiency index, growth index and valuation index. Operating cash flow declined 158.2% from -$6.78M to -$17.52M, net income declined 140.69% from -$14.86M to -$35.77M, and earnings per share declined from -$0.0382 to -$0.0828.
CytoDyn Inc. (CYDY) was downgraded to D+ from C on 4/13/2020 due to a significant decline in the efficiency index, growth index and valuation index. Operating cash flow declined 158.2% from -$6.78M to -$17.52M, net income declined 140.69% from -$14.86M to -$35.77M, and earnings per share declined from -$0.0382 to -$0.0828.
C
Hold
2/4/2020Upgraded
CytoDyn Inc. (CYDY) was upgraded to C from C- on 2/4/2020 due to a major increase in the total return index and growth index.
CytoDyn Inc. (CYDY) was upgraded to C from C- on 2/4/2020 due to a major increase in the total return index and growth index.
C
Hold
1/10/2020Upgraded
CytoDyn Inc. (CYDY) was upgraded to C- from D on 1/10/2020 due to a significant increase in the efficiency index, volatility index and total return index. Net income increased 8.06% from -$16.16M to -$14.86M.
CytoDyn Inc. (CYDY) was upgraded to C- from D on 1/10/2020 due to a significant increase in the efficiency index, volatility index and total return index. Net income increased 8.06% from -$16.16M to -$14.86M.
D
Sell
10/10/2019Downgrade
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 10/10/2019 due to a significant decline in the efficiency index and volatility index. Net income declined 8.53% from -$14.89M to -$16.16M.
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 10/10/2019 due to a significant decline in the efficiency index and volatility index. Net income declined 8.53% from -$14.89M to -$16.16M.
D
Sell
8/19/2019Upgraded
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 8/19/2019 due to a significant increase in the efficiency index and growth index. Operating cash flow increased 35.56% from -$14.76M to -$9.51M.
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 8/19/2019 due to a significant increase in the efficiency index and growth index. Operating cash flow increased 35.56% from -$14.76M to -$9.51M.
D
Sell
1/10/2019Upgraded
CytoDyn Inc. (CYDY) was upgraded to D from D- on 1/10/2019 due to an increase in the growth index. Earnings per share increased from -$0.0659 to -$0.06.
CytoDyn Inc. (CYDY) was upgraded to D from D- on 1/10/2019 due to an increase in the growth index. Earnings per share increased from -$0.0659 to -$0.06.
D
Sell
12/20/2018Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 12/20/2018 due to a decline in the solvency index, growth index and volatility index. Earnings per share declined from -$0.0454 to -$0.0659, operating cash flow declined 28.54% from -$6.98M to -$8.97M, and EBIT declined 20.47% from -$11.2M to -$13.49M.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 12/20/2018 due to a decline in the solvency index, growth index and volatility index. Earnings per share declined from -$0.0454 to -$0.0659, operating cash flow declined 28.54% from -$6.98M to -$8.97M, and EBIT declined 20.47% from -$11.2M to -$13.49M.
D
Sell
2/12/2018Upgraded
CytoDyn Inc. (CYDY) was upgraded to D from D- on 2/12/2018 due to an increase in the volatility index and total return index.
CytoDyn Inc. (CYDY) was upgraded to D from D- on 2/12/2018 due to an increase in the volatility index and total return index.
D
Sell
1/26/2018Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 1/26/2018 due to a decline in the total return index.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 1/26/2018 due to a decline in the total return index.
D
Sell
1/9/2018Upgraded
CytoDyn Inc. (CYDY) was upgraded to D from D- on 1/9/2018 due to an increase in the growth index and valuation index. Operating cash flow increased 15.86% from -$7M to -$5.89M, and earnings per share increased from -$0.0766 to -$0.07.
CytoDyn Inc. (CYDY) was upgraded to D from D- on 1/9/2018 due to an increase in the growth index and valuation index. Operating cash flow increased 15.86% from -$7M to -$5.89M, and earnings per share increased from -$0.0766 to -$0.07.
D
Sell
11/3/2017Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 11/3/2017 due to a large decline in the growth index, volatility index and solvency index. The quick ratio declined from 0.29 to 0.09, earnings per share declined from -$0.0457 to -$0.0766, and debt to equity increased from -0.96 to -0.54.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 11/3/2017 due to a large decline in the growth index, volatility index and solvency index. The quick ratio declined from 0.29 to 0.09, earnings per share declined from -$0.0457 to -$0.0766, and debt to equity increased from -0.96 to -0.54.
D
Sell
7/21/2017Upgraded
CytoDyn Inc. (CYDY) was upgraded to D from D- on 7/21/2017 due to an increase in the volatility index, valuation index and growth index. Earnings per share increased from -$0.0571 to -$0.0457, operating cash flow increased 18.5% from -$8.79M to -$7.17M, and EBIT increased 2.71% from -$8.02M to -$7.8M.
CytoDyn Inc. (CYDY) was upgraded to D from D- on 7/21/2017 due to an increase in the volatility index, valuation index and growth index. Earnings per share increased from -$0.0571 to -$0.0457, operating cash flow increased 18.5% from -$8.79M to -$7.17M, and EBIT increased 2.71% from -$8.02M to -$7.8M.
D
Sell
1/13/2017Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 1/13/2017 due to a decline in the growth index and valuation index. EBIT declined 14.89% from -$5.36M to -$6.16M.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 1/13/2017 due to a decline in the growth index and valuation index. EBIT declined 14.89% from -$5.36M to -$6.16M.
D
Sell
12/30/2016Upgraded
CytoDyn Inc. (CYDY) was upgraded to D from D- on 12/30/2016 due to an increase in the total return index, volatility index and valuation index.
CytoDyn Inc. (CYDY) was upgraded to D from D- on 12/30/2016 due to an increase in the total return index, volatility index and valuation index.
D
Sell
12/15/2016Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 12/15/2016 due to a significant decline in the total return index, volatility index and solvency index. The quick ratio declined from 2.69 to 1.46.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 12/15/2016 due to a significant decline in the total return index, volatility index and solvency index. The quick ratio declined from 2.69 to 1.46.
D
Sell
8/4/2016Downgrade
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 8/4/2016 due to a noticeable decline in the total return index.
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 8/4/2016 due to a noticeable decline in the total return index.
D
Sell
7/20/2016Upgraded
CytoDyn Inc. (CYDY) was upgraded to D+ from D- on 7/20/2016 due to a noticeable increase in the total return index, efficiency index and solvency index.
CytoDyn Inc. (CYDY) was upgraded to D+ from D- on 7/20/2016 due to a noticeable increase in the total return index, efficiency index and solvency index.
D
Sell
4/14/2016Downgrade
CytoDyn Inc. (CYDY) was downgraded to D- from D on 4/14/2016 due to a large decline in the efficiency index, valuation index and growth index. Operating cash flow declined 238.4% from -$3.27M to -$11.06M, and EBIT declined 74.48% from -$2.89M to -$5.05M.
CytoDyn Inc. (CYDY) was downgraded to D- from D on 4/14/2016 due to a large decline in the efficiency index, valuation index and growth index. Operating cash flow declined 238.4% from -$3.27M to -$11.06M, and EBIT declined 74.48% from -$2.89M to -$5.05M.
D
Sell
3/11/2016Downgrade
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
D
Sell
2/1/2016Upgraded
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 2/1/2016 due to a large increase in the volatility index and total return index.
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 2/1/2016 due to a large increase in the volatility index and total return index.
D
Sell
1/15/2016Downgrade
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 1/15/2016 due to a noticeable decline in the volatility index.
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 1/15/2016 due to a noticeable decline in the volatility index.
D
Sell
1/12/2016Downgrade
CytoDyn Inc. (CYDY) was downgraded to D+ from C on 1/12/2016 due to a significant decline in the efficiency index and total return index. Net income declined 40.81% from -$8.9M to -$5.26M, and total capital declined 27.24% from -$3.72M to -$2.71M.
CytoDyn Inc. (CYDY) was downgraded to D+ from C on 1/12/2016 due to a significant decline in the efficiency index and total return index. Net income declined 40.81% from -$8.9M to -$5.26M, and total capital declined 27.24% from -$3.72M to -$2.71M.
C
Hold
12/28/2015Upgraded
CytoDyn Inc. (CYDY) was upgraded to C from C- on 12/28/2015 due to a large increase in the volatility index and total return index.
CytoDyn Inc. (CYDY) was upgraded to C from C- on 12/28/2015 due to a large increase in the volatility index and total return index.
C
Hold
10/9/2015Upgraded
CytoDyn Inc. (CYDY) was upgraded to C- from D+ on 10/9/2015 due to a significant increase in the efficiency index and valuation index.
CytoDyn Inc. (CYDY) was upgraded to C- from D+ on 10/9/2015 due to a significant increase in the efficiency index and valuation index.
D
Sell
5/13/2015Upgraded
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 5/13/2015 due to a noticeable increase in the total return index.
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 5/13/2015 due to a noticeable increase in the total return index.
D
Sell
4/28/2015Downgrade
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 4/28/2015 due to a decline in the total return index and volatility index.
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 4/28/2015 due to a decline in the total return index and volatility index.
D
Sell
4/10/2015Upgraded
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 4/10/2015 due to an increase in the growth index and total return index. EBIT increased 10.05% from -$2.99M to -$3.29M.
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 4/10/2015 due to an increase in the growth index and total return index. EBIT increased 10.05% from -$2.99M to -$3.29M.
D
Sell
3/19/2015Downgrade
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 3/19/2015 due to a noticeable decline in the volatility index and total return index.
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 3/19/2015 due to a noticeable decline in the volatility index and total return index.
D
Sell
3/4/2015Upgraded
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 3/4/2015 due to an increase in the total return index.
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 3/4/2015 due to an increase in the total return index.
D
Sell
2/13/2015Downgrade
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 2/13/2015 due to a large decline in the volatility index and total return index.
CytoDyn Inc. (CYDY) was downgraded to D from D+ on 2/13/2015 due to a large decline in the volatility index and total return index.
D
Sell
1/13/2015Upgraded
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 1/13/2015 due to a significant increase in the volatility index, solvency index and efficiency index. Debt to equity declined from 6.51 to -1.71, and net income increased 47.47% from -$3.38M to -$4.98M.
CytoDyn Inc. (CYDY) was upgraded to D+ from D on 1/13/2015 due to a significant increase in the volatility index, solvency index and efficiency index. Debt to equity declined from 6.51 to -1.71, and net income increased 47.47% from -$3.38M to -$4.98M.
OTC PK
03/13/2025 1:03PM Eastern
Quotes delayed
